Top

17-07-2017 | Breast cancer | Article

Breast cancer family history leads to early breast cancer detection and optimal management

Journal: Cancer Causes & Control

Authors: Anne-Sophie Jannot, Massimo Usel, Christine Bouchardy, Hyma Schubert, Elisabetta Rapiti

Publisher: Springer International Publishing

Abstract

Purpose

We investigated whether the relationship between family history (FH) of breast cancer and survival of women with breast cancer is related to the quality of care received, once adjusted for other prognostic variables using data from the Geneva population-based cancer registry and quality of care indicators defined by the European Society of breast cancer specialists (EUSOMA).

Methods

We included non-metastatic malignant breast tumor patients who had their surgery between 2001 and 2010. We assessed the association between FH and patient and tumor characteristics on one hand, and each quality of care indicator and an overall score of quality of care, on the other hand, through logistic regression. We assessed the impact of FH and the quality of care-score on 5-year survival with Cox regression adjusting for patient and tumor characteristics.

Results

2,672 patients were included in the study. Women with a positive FH were younger, more likely from Switzerland, screen detected, had positive estrogen and progesterone receptor status, and had smaller and ductal tumors. A positive FH was also associated with better management for several quality indicators. Women with a positive FH had a better crude survival (Hazard Ratio 0.61, p = 0.006). This association was not substantially affected when adjusting for quality of care. However, the effect of FH did not persist when also adjusting for patient and tumor characteristics.

Conclusions

A positive FH of breast cancer is associated with earlier breast cancer diagnosis, better tumor features, and higher quality of care. These factors explain the better survival observed among breast cancer women with a positive FH as compared to women without positive FH.

Chang ET, Milne RL, Phillips KA, Figueiredo JC, Sangaramoorthy M, Keegan TH, Andrulis IL, Hopper JL, Goodwin PJ, O’Malley FP, Weerasooriya N, Apicella C, Southey MC, Friedlander ML, Giles GG, Whittemore AS, West DW, John EM (2009) Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry. Breast Cancer Res Treat 117(1):167–176CrossRefPubMed

Russo A, Herd-Smith A, Gestri D, Bianchi S, Vezzosi V, Rosselli del Turco M, Cardona G (2002) Does family history influence survival in breast cancer cases? Int J Cancer 99(3):427–430CrossRefPubMed

Slattery ML, Berry TD, Kerber RA (1993) Is survival among women diagnosed with breast cancer influenced by family history of breast cancer? Epidemiology 4(6):543–548CrossRefPubMed

Melvin JC, Wulaningsih W, Hana Z, Purushotham AD, Pinder SE, Fentiman I, Gillett C, Mera A, Holmberg L, Van Hemelrijck M (2016) Family history of breast cancer and its association with disease severity and mortality. Cancer Med 5(5):942–949. doi:10.1002/cam4.648 CrossRefPubMedPubMedCentral

Gonzalez-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, Theriault R, Booser D, Buzdar AU, Hortobagyi GN, Arun B (2005) Women age ≤35 years with primary breast carcinoma. Cancer 103(12):2466–2472CrossRefPubMed

Malone KE, Daling JR, Weiss NS, McKnight B, White E, Voigt LF (1996) Family history and survival of young women with invasive breast carcinoma. Cancer 78(7):1417–1425CrossRefPubMed

Mohammed SN, Smith P, Hodgson SV, Fentiman IS, Miles DW, Barnes DM, Millis RR, Rubens RD (1998) Family history and survival in premenopausal breast cancer. Br J Cancer 77(12):2252–2256CrossRefPubMedPubMedCentral

Jobsen JJ, van der Palen J, Brinkhuis M, Ong F, Struikmans H (2016) Long-term effects of first degree family history of breast cancer in young women: recurrences and bilateral breast cancer. Acta Oncol 55(4):449–454. doi:10.3109/0284186X.2015.1074281 CrossRefPubMed

Verkooijen HM, Chappuis PO, Rapiti E, Vlastos G, Fioretta G, Sarp S, Sappino AP, Schubert H, Bouchardy C (2006) Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer 94(2):231–238CrossRefPubMedPubMedCentral

10.

Verkooijen HM, Rapiti E, Fioretta G, Vinh-Hung V, Keller J, Benhamou S, Vlastos G, Chappuis PO, Bouchardy C (2009) Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups. Cancer Causes Control 20(9):1689–1696CrossRefPubMed

11.

Malone KE, Daling JR, Doody DR, O’Brien C, Resler A, Ostrander EA, Porter PL (2011) Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer. Cancer Epidemiol Biomarkers Prev 20(12):2560–2571CrossRefPubMedPubMedCentral

12.

Del Turco MR, Ponti A, Bick U, Biganzoli L, Cserni G, Cutuli B, Decker T, Dietel M, Gentilini O, Kuehn T, Mano MP, Mantellini P, Marotti L, Poortmans P, Rank F, Roe H, Scaffidi E, van der Hage JA, Viale G, Wells C, Welnicka-Jaskiewicz M, Wengstom Y, Cataliotti L (2010) Quality indicators in breast cancer care. Eur J Cancer 46(13):2344–2356CrossRefPubMed

13.

Bouchardy C (2014) Cancer incidence in Switzerland, Geneva (2003–2007). In: Forman DBF, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J (eds) Cancer incidence in five continents, vol X. IARC Scientific Publication No 164. International Agency for Research on Cancer, Lyon, pp 840–841

14.

ICD-O International Classification of Diseases for Oncology-3rd edition (2000) International Classification of Diseases for Oncology, 3rd ed. Geneva

15.

Cortesi L, Masini C, Cirilli C, Medici V, Marchi I, Cavazzini G, Pasini G, Turchetti D, Federico M (2010) Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer. BMC Cancer 10:90. doi:10.1186/1471-2407-10-90 CrossRefPubMedPubMedCentral

16.

Eccles BK, Copson ER, Cutress RI, Maishman T, Altman DG, Simmonds P, Gerty SM, Durcan L, Stanton L, Eccles DM, PSS Group (2015) Family history and outcome of young patients with breast cancer in the UK (POSH study). Br J Surg 102(8):924–935. doi:10.1002/bjs.9816 CrossRefPubMed

17.

Thalib L, Wedren S, Granath F, Adami HO, Rydh B, Magnusson C, Hall P (2004) Breast cancer prognosis in relation to family history of breast and ovarian cancer. Br J Cancer 90(7):1378–1381CrossRefPubMedPubMedCentral

18.

Figueiredo JC, Ennis M, Knight JA, McLaughlin JR, Hood N, O’malley F, Andrulis IL, Goodwin PJ (2007) Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Res Treat 105(1):69–80CrossRefPubMed

19.

Schwab FD, Burki N, Huang DJ, Heinzelmann-Schwarz V, Schmid SM, Vetter M, Schotzau A, Guth U (2014) Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancer. Fam Cancer 13(1):99–107. doi:10.1007/s10689-013-9682-3 CrossRefPubMed

20.

Lijovic M, Davis SR, Fradkin P, Bradbury J, La China M, Schwarz M, Wolfe R, Farrugia H, Bell RJ (2009) The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer. Fam Cancer 8(4):299–305. doi:10.1007/s10689-009-9236-x CrossRefPubMed

21.

Daling JR, Malone KE, Voigt LF, White E, Weiss NS (1994) Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst 86(21):1584–1592CrossRefPubMed

22.

Tracy KA, Quillin JM, Wilson DB, Borzelleca J, Jones RM, McClish D, Bowen D, Bodurtha J (2008) The impact of family history of breast cancer and cancer death on women’s mammography practices and beliefs. Genet Med 10(8):621–625. doi:10.1097/GIM.0b013e31817c0355 CrossRefPubMed

23.

Verkooijen HM, Fioretta G, Chappuis PO, Vlastos G, Sappino AP, Benhamou S, Bouchardy C (2004) Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Ann Oncol 15(2):350–353CrossRefPubMed